Clinical application of plasma growth differentiation factor-15 and ABC bleeding risk score in predicting bleeding risk in elderly patients with non-valvular atrial fibrillation on non-vitamin K antagonist oral anticoagulants
Author:
Affiliation:

1.Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510123, China;2.Department of Cardiology, Kiang Wu Hospital, Macau 999078, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • | | | |
  • Comments
    Abstract:

    Aim To explore the ability of serum growth differentiation factor-15 (GDF-15) and the ABC (age, biomarkers, clinical history) bleeding risk score based on this in predicting hemorrhage events in elderly (age≥65 years) patients with non-valvular atrial fibrillation (NVAF) after oral administration of non-vitamin K antagonist oral anticoagulants (NOAC). Methods Elderly inpatients who were first diagnosed as NVAF and treated with NOAC were selected. The GDF-15 concentration in serum was analyzed and clinical data were collected in each enrolled patient. The ABC bleeding risk score was calculated, which is essential on biomarkers including GDF-15, and HAS-BLED bleeding risk score. The patients were divided into groups according to the occurrence of various bleeding events(major bleeding (MB), clinically relevant non-major gastrointestinal bleeding (CRNM-GIB),minor bleeding, and no bleeding events) during follow-up. The ABC bleeding risk score and HAS-BLED bleeding risk score were evaluated and compared for predicting various degrees of bleeding events groups. Results During the (19.92±6.83) months follow-up period, 49 cases (49/2,4.5%) had bleeding events, including 3 cases of cerebral hemorrhage, 19 cases of CRNM-GIB, and 27 cases of minor bleeding. Receiver operating characteristic (ROC)curve showed that serum GDF-15 concentration had predictive value in predicting CRNM-GIB (AUC 0.8,5%CI: 0.645~0.835, P<0.001) and all bleeding events (AUC 0.0,5%CI:0.690~0.727, P<0.001), and ABC bleeding risk score had predictive value in predicting CRNM-GIB (AUC 0.8,5%CI:0.552~0.824, P<0.001) and all bleeding events (AUC 0.9,5%CI:0.579~0.779, P<0.001).Compared with the HAS-BLED bleeding risk score, the ABC bleeding risk score had a higher ability to predict cerebral hemorrhage (AUC 0.8,5%CI:0.752~0.985 for ABC score vs. AUC 0.5,5%CI: 0.556~0.933 for HAS-BLED score, net reclassification improvement (NRI) 84.17%, P=0.001), less ability to predict CRNM-GIB (AUC 0.8,5%CI:0.552~0.824 for ABC score vs. AUC 0.4,5%CI:0.639~0.849 for HAS-BLED score, NRI -23.96%, P=0.025). Conclusion GDF-15 concentration in blood has predictive value for the bleeding risk of oral NOAC in elderly NVAF patients. Compared with HAS-BLED, ABC bleeding risk score can improve the ability to predict cerebral hemorrhage.

    Reference
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Oü U Fan, CHONG Tou Kun, SIO Cham Chio, LEONG Lat Lon, LEONG Lap Tong, WU Wei. Clinical application of plasma growth differentiation factor-15 and ABC bleeding risk score in predicting bleeding risk in elderly patients with non-valvular atrial fibrillation on non-vitamin K antagonist oral anticoagulants[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(5):423-430.

Copy
Related Videos

Share
Article Metrics
  • Abstract:175
  • PDF: 709
  • HTML: 0
  • Cited by: 0
History
  • Received:December 10,2021
  • Revised:March 07,2022
  • Online: May 10,2022
Article QR Code